Lotus Laboratories

Lotus Laboratories is a premier Contract Research Organization (CRO) based in Bangalore, India, specializing in clinical research services for the global pharmaceutical and generic industries. Established in 2001, the company is a leader in Bioavailability and Bioequivalence (BA/BE) studies, which are essential for the development and regulatory approval of generic drugs and biosimilars. Lotus operates state-of-the-art clinical facilities and bioanalytical laboratories that comply with international standards and have been audited by major regulatory agencies including the US FDA, EMA, and ANVISA. Following its acquisition by Actavis in 2005, and subsequently by Teva Pharmaceutical Industries in 2016, the company has been integrated into Teva's global R&D infrastructure. It provides a comprehensive range of services including Phase I-IV clinical trials, bioanalytical testing, and data management, supporting pharmaceutical clients in navigating complex regulatory pathways for global market entry.